← Open Payments lookup

MANUEL GUILLEN: Open Payments

NPI 1871819219 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,327 in 73 payments from 15 companies in 2025. Trend: 2023 $137 · 2024 $237 · 2025 $1,327

Food & beverage: $1,318Education: $9
CompanyPaymentsAmount
ABBVIE INC.18$271
Otsuka America Pharmaceutical, Inc.10$207
Takeda Pharmaceuticals U.S.A., Inc.12$145
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$144
Alkermes, Inc.4$80
Almatica Pharma LLC4$71
Neurocrine BioSciences, Inc.3$70
E.R. Squibb & Sons, L.L.C.3$66
Lundbeck LLC3$66
Janssen Pharmaceuticals, Inc2$54

Products named: VRAYLAR, REXULTI, TRINTELLIX, CAPLYTA, LOREEV XR, INGREZZA, COBENFY, ARISTADA.

Industry payments across TX — which companies pay providers there.